News
Explore opportunities with Novartis below.
Novartis is proud to share that CEO Vas Narasimhan, M.D., has been named to the 2025 TIME100 Health list—recognizing 100 of the most influential people driving the future of global health.
Explore opportunities with Novartis below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search. Equipment Operator (m/w/d), 12 Monaten Befristet (Befristet) ...
Associate Analyst-Master Data Management Regular, Full time Innovative Medicines India Hyderabad (Office) 08 Mei 2025 ...
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
QA Operations Team Leader, Qualified person (m/f/d), Kundl, Austria Regular, Full time Universal Hierarchy Node Austria Kundl maio 06, 2025 Vodja kontrole kakovosti (m/ž/d) / QC Lead (m/f/d), Mengeš ...
At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Schlaganfall-Lotsenprojekt in der Hauptstadtregion Berlin/Brandenburg gestartet. Es handelt sich um ein gemeinsames Kooperationsprojekt von der Stiftung Deutsche Schlaganfall-Hilfe, dem Jüdischen ...
FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results